Business
Sernova Retains FronTier Flex for Canadian Investor Relations and Marketing
(via TheNewswire) LONDON, ONTARIO - November 9, 2018- Sernova Corp. (TSX-V...
About this update from Sernova Biotherapeutics Inc
[{"type":"text","content":"Sernova Retains FronTier Flex for Canadian Investor Relations and Marketing(via TheNewswire)\n \n \nLONDON, ONTARIO - November 9, 2018- Sernova Corp. (TSX-V: SVA) (OTCQB: SEOVF) (FSE: PSH), a clinical-stage regenerative medicine company, announces that it has engaged FronTier Flex, an investor relations (IR) and marketing group based in Toronto, Ontario Canada to provide Canadian IR and strategic marketing services. \n\n\n \nSernova President and CEO Dr. Philip Toleikis commented, \"FronTier's engagement falls within the expanded communications strategy Sernova is implementing to help investors and shareholders stay well-informed as we advance our new US diabetes Phase I/II clinical study and other programs. FronTier's media experience will increase Sernova's visibility and reach into the investment community through strategic messaging and investor outreach.\" \n\n\n \nThrough their established network of financial industry professionals and marketing service providers, FronTier will assist the corporation by increasing market awareness for the corporation using a number of financial market communications initiatives, including facilitating in-person introductions for the corporation with institutional and retail brokers in Toronto and other financial capitals, and through media distribution on national television, radio and multiple online channels.\n\n\n \nUnder the terms of the engagement, FronTier has been retained for a 12-month period for aggregate remuneration of $87,000 plus expenses. \n\n\n \nAbout Sernova Corp\n\n\n \nSernova Corp is developing regenerative medicine therapeutic technologies using a medical device and immune protected therapeutic cells to improve the treatment and quality of life of people with chronic metabolic diseases such as insulin-dependent diabetes, blood disorders including hemophilia, and other diseases treated through replacement of proteins or hormones missing or in short supply within the body. For more information, please visit www.sernova.com\n\n \n \nFor further information contact:\n\n \n \nDominic Gray, Corporate Communications\n\n\n \nTel: (519) 858-5126\n\n\n \[email protected]\n\n\n \nwww.sernova.com\n\n \n \nPhilip Toleikis, Ph.D., President and CEO\n\n\n \nTel: (519) 858-5184\n\n\n \[email protected]\n\n\n \nwww.sernova.com\n\n \n \nRay Matthews & Associates\n\n\n \nTe...